Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer

被引:26
|
作者
Haroun, Iman
Graham, Tracy
Poll, Aletta
Sun, Ping
Hill, Kimberley [1 ]
Weitzner, Eleanor [2 ]
Narod, Steven [3 ]
Warner, Ellen [3 ]
机构
[1] Sunnybrook Odette Canc Ctr, Dept Med, Div Med Oncol, Toronto, ON, Canada
[2] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON M5S 1A1, Canada
关键词
BRCA1; MRI; Mastectomy; BRCA2; Surveillance; BILATERAL PROPHYLACTIC MASTECTOMY; BRCA2 MUTATION CARRIERS; TAMOXIFEN; IMPACT;
D O I
10.1016/j.breast.2011.01.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To determine the reasons that motivate women in a cohort of women under intensive surveillance for breast cancer to undergo risk-reducing mastectomy (RRM). Patients and methods: Women with a BRCA1 or BRCA2 mutation who were enrolled in an MRI-based breast screening study were eligible to participate in this survey. A self-administered questionnaire was given to women who did, and who did not terminate annual MRI-based surveillance in order to undergo RRM. The questionnaire included information on family history, risk perception and satisfaction with screening. In addition, women were asked to provide the principal reason for their choice of having preventive surgery or not, and were asked about their satisfaction with this choice. Results: 246 women without breast cancer participated in the study. Of these, 39 women (16%) elected to have RRM at some point after initiating screening. Although women who had a mother or sister with breast cancer were more likely to opt for RRM than were women with no affected first-degree relative (21% versus 10%) this did not reach statistical significance. Women who perceived their breast cancer risk to be greater than 50% were more likely to opt for RRM than were women who estimated their risk to be less than 50% (19% versus 6%). Fear of cancer was the most common reason cited for choosing to have RRM (38% of respondents) followed by having had a previous cancer, (25%), then concern over their children (16%). Conclusion: Among women with a BRCA mutation who are enrolled in an MRI-based screening program, a high perception of personal breast cancer risk and a history of breast cancer in a first-degree relative are predictors of the decision to have RRM. (C) 2011 Published by Elsevier Ltd.
引用
收藏
页码:254 / 258
页数:5
相关论文
共 50 条
  • [21] Risk-Reducing Mastectomy and Breast Reconstruction: Indications and Evidence for Current Management Strategies
    Eisemann, Bradley S.
    Spiegel, Aldona J.
    CLINICS IN PLASTIC SURGERY, 2018, 45 (01) : 129 - +
  • [22] The Importance of Risk-Reducing Prophylactic Mastectomy in Breast Cancer (BRCA) Carriers: A Case Report
    Ochaney, Priyanka
    Patel, Kornai
    Haq, Furcian
    Reese, Robyn
    Igel, Stephen
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (08)
  • [23] A systematic review of women's satisfaction and regret following risk-reducing mastectomy
    Braude, Lucy
    Kirsten, Laura
    Gilchrist, Jemma
    Juraskova, Ilona
    PATIENT EDUCATION AND COUNSELING, 2017, 100 (12) : 2182 - 2189
  • [24] Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer
    Antill, Y
    Reynolds, J
    Young, MA
    Kirk, J
    Tucker, K
    Bogtstra, T
    Wong, S
    Dudding, T
    Di Iulio, J
    Phillips, KA
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (05) : 621 - 628
  • [25] Update on Screening Breast MRI in High-Risk Women
    Boetes, C.
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2011, 38 (01) : 149 - +
  • [26] Decision-making for bilateral risk-reducing mastectomy for an increased lifetime breast cancer risk: A qualitative metasynthesis
    Torrisi, Christa
    Wareg, Nuha K.
    Anbari, Allison Brandt
    PSYCHO-ONCOLOGY, 2024, 33 (03)
  • [27] Breast reconstruction after risk-reducing mastectomy in BRCA mutation carriers
    Nagura, Naomi
    Hayashi, Naoki
    Takei, Junko
    Yoshida, Atsushi
    Ochi, Tomohiro
    Iwahira, Yoshiko
    Yamauchi, Hideko
    BREAST CANCER, 2020, 27 (01) : 70 - 76
  • [28] Short-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review
    Ntowe, Koumani W.
    Lee, Michael S.
    Yi, Victoria N.
    Kaplan, Samantha J.
    Phillips, Brett T.
    Chiba, Akiko
    Plichta, Jennifer K.
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (04) : 2510 - 2525
  • [29] Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis
    Metcalfe, Kelly
    Huzarski, Tomasz
    Gronwald, Jacek
    Kotsopoulos, Joanne
    Kim, Raymond
    Moller, Pal
    Pal, Tuya
    Aeilts, Amber
    Eisen, Andrea
    Karlan, Beth
    Bordeleau, Louise
    Tung, Nadine
    Olopade, Olufunmilayo
    Zakalik, Dana
    Singer, Christian F.
    Foulkes, William
    Couch, Fergus
    Neuhausen, Susan L.
    Eng, Charis
    Sun, Ping
    Lubinski, Jan
    Narod, Steven A.
    BRITISH JOURNAL OF CANCER, 2023, 130 (2) : 269 - 274
  • [30] Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer
    Hidetaka Nomura
    Ai Ikki
    Atsushi Fusegi
    Makiko Omi
    Yoichi Aoki
    Sachiho Netsu
    Terumi Tanigawa
    Maki Matoda
    Sanshiro Okamoto
    Kohei Omatsu
    Takeshi Nakajima
    Arisa Ueki
    Akiko Tonooka
    Hiroyuki Kanao
    International Journal of Clinical Oncology, 2021, 26 : 2331 - 2337